To assess tumor specificity of DC-stimulated ANRU CD8+ T cell products, autologous ANRU DCs were loaded with tumor lysate, neoantigen 9mer peptides (ETV6 or NUP210) or EpiTCer beads. The gene discussed is CD8A; the disease is neoplasm.